NCT03028675View on ClinicalTrials.gov

pH-weighted MRI in Multiple Sclerosis: A Surrogate Marker of Tissue Metabolic Stress

CompletedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

August 10, 2018

Study Completion Date

August 10, 2018

Conditions
Multiple Sclerosis
Interventions
OTHER

MRI Scan

MRI scans will consist of a 1-hour brain scan for both patients and controls.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03028675 - pH-weighted MRI in Multiple Sclerosis: A Surrogate Marker of Tissue Metabolic Stress | Biotech Hunter | Biotech Hunter